Radiopharm Theranostics Ltd
ASX:RAD
Prices of ASX stocks are not being updated. The latest RAD price on Alpha Spread is from Oct 14, 2026. Financials, forecasts and intrinsic value keep updating.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Radiopharm Theranostics Ltd
ASX:RAD
|
AU |
|
Sipef NV
F:BZ3
|
BE |
|
Consolidated Edison Inc
NYSE:ED
|
US |
|
E
|
ENM Holdings Ltd
F:EMD
|
HK |
|
Konica Minolta Inc
TSE:4902
|
JP |
|
Omni Bridgeway Ltd
ASX:OBL
|
AU |
|
Impala Platinum Holdings Ltd
OTC:IMPUF
|
ZA |
|
C
|
Compagnie de Saint Gobain SA
F:GOB
|
FR |
|
Enensys Technologies SA
F:20U
|
FR |
|
Genoway SA
PAR:ALGEN
|
FR |
|
North Energy ASA
F:RN2
|
NO |
|
Applovin Corp
NASDAQ:APP
|
US |
|
STRABAG SE
VSE:STR
|
AT |
|
Kornit Digital Ltd
NASDAQ:KRNT
|
IL |
|
First National Financial Corp
F:63Z
|
CA |
|
PLS Group Ltd
ASX:PLS
|
AU |
Bankruptcy Probability
Radiopharm Theranostics Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Radiopharm Theranostics Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
R
|
Radiopharm Theranostics Ltd
ASX:RAD
|
23.6m AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
505.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
249.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
207.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
103.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
91.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
55.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Radiopharm Theranostics Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Radiopharm Theranostics Ltd has no debt.
You can find a full breakdown on its Balance Sheet.